The therapeutic efficacy of neuromodulation treatments has significantly improved over the past decade. These developments have led to the understanding of how neuromodulation functions, which anatomical locations are more clinically effective to target, and how we can transmit electrical signals in a better and safer way. As current technology improves and clinical applications expand, the continued evolution of neuromodulation technology brings with it the promise of addressing the needs of both patients and physicians.
In this edition of MedTech Outlook, we present some of the most promising solutions in the neuromodulation space. The issue features thought leadership articles from Lawrance Weinstein, Chief Medical Officer, American Addiction Centers, Chad M. Teven, M.D. and Michael A. Howard, M.D., Microsurgery and Complex Reconstruction, Division of Plastic Surgery, Northwestern Medicine Lake Forest Hospital, Dr. Paul Wright, Senior Vice President and System Chair of the Neuroscience Institute, Nuvance Health, and Prashant Kumar, Medical Director, Pain Medicine, Saint Vincent Hospital. The edition also showcases innovative solutions from Neuro MD, which offers the most advanced, FDA-cleared corrective therapy device to restore a patient’s lower back health and provide lasting pain relief. Neuro MD’s device is equipped with pre-set, clinically studied neuromuscular electrical stimulation (NMES) parameters, which facilitates the delivery of proven electrical stimulation to correct the source of the pain.
Leafing through these pages will give you comprehensive insights into the different cutting-edge solutions in the neuromodulation arena that can help you make informed choices for impactful pain relief and restoration of function.
